6:45 a.m. |
Registration
|
7:30 a.m. |
Introduction by Moderators
|
7:35 a.m. |
2023 Harry Hirsch Leiter Award Recipient:
Efficacy of a Novel Antibiotic Drug Combination Towards Multi-Drug Resistant Ocular Pathogens
Rachel Wozniak, MD, PhD
|
7:42 a.m. |
1. Cefiderocol is Effective against Numerous Gram-Negative Keratitis Isolates In Vitro
Jonathan B. Mandell, MS, PhD |
7:49 a.m. |
2. Automated Detection of Bacterial Keratitis on Whole Slide Images of Gram Stains Using Dual Stream Multiple Instance Learning
Jad F. Assaf, MD |
7:56 a.m. |
3. Identifying the Ocular Surface Microbiome and Immune Cells in Healthy Subjects
Simran Mangwani-Mordani, MD, MSc |
8:03 a.m. |
4. Clinical and Genomic Profile of Antimicrobial Resistance Among Bacterial Keratitis Isolates at Johns Hopkins
Nakul Shekhawat, MD, MPH |
8:10 a.m. |
5. Adaptive Nanopore Sequencing for Rapid Diagnosis of Infectious Keratitis
Marcus Toral, MD, PhD |
8:17 a.m. |
6. Seasonal Hyperacute Panuveitis (SHAPU) is Associated with Streptococcus pneumonia Infection
Kenji Nakamichi |
8:24 a.m. |
7. Long-Term Graft Survival after Rose Bengal Photodynamic Antimicrobial Therapy for Infectious Keratitis and Keratoplasty
Jordan J. Huang, MD
|
8:31 a.m. |
8. Rose Bengal Photodynamic Therapy (PDAT) for Mycobacterium abscessus Keratitis: In Vitro Efficacy and Clinical Outcomes
Salomon Merikansky, MD |
8:38 a.m. |
9. Association of weather variables with pathogens contributing to conjunctivitis worldwide
Daisy Yan, MPH |
8:45 a.m. |
10. Comparison of Pain Interference on Quality of Life in Neuropathic Corneal Pain (NCP) and Dry Eye Disease (DED) Patients with and without Non-ocular Facial Pain
Leyla Mirzaee, DMSc |
8:52 a.m. |
11. Neurotrophic keratitis may have an Underlying Inflammatory or Autoimmune Etiology
Ana Balbuena-Pareja, MSc |
8:59 a.m. |
12. Alternative Photosensitizer Evaluation in fungal keratitis: In vitro Inhibition and Bbiophysical Profile Analysis
James Lai |
9:06 a.m. |
13. Moved to Poster Presentaton
|
9:13 a.m. |
14. Prediction of Subepithelial Infiltrates (SEI) following adenovirus D8 keratoconjunctivitis via Machine Learning
Behrouz Rahimi, MD |
9:20 a.m. |
BREAK and Posters
|
9:45 a.m. |
15. Clinico - molecular Analysis of Patients with microbial keratitis Showing Unusual Oval or Spherical Structures in Direct Microscopic Examination of Corneal Scraping
Savitri Sharma, MD |
9:52 a.m. |
16. Topical Tacrolimus as Adjunctive Therapy in Mycotic Corneal Ulcers-A Pilot Study
Kunal Mandlik, MD |
9:59 a.m |
17. Evaluation of the Ocular Surface Epithelium Using Artificial Intelligence and High-Resolution Anterior Segment Optical Coherence Tomography
Jason A. Greenfield, BA |
10:06 a.m. |
18. Infectious Etiologies of Conjunctival Tumors
Michael Antonietti, BS |
10:13 a.m. |
19. IL-6 Amplifies Alloimmunity by Inducing Dysfunctional IFN-γ Secreting Treg through the VEGFA-VEGFR1 Axis
Seokjoo Lee, PhD, DSc |
10:20 a.m. |
20. In vivo TNFRSF25 and IL-2R Stimulation in Mice Induces a Regulatory Environment within Multiple Tissues including the Ocular Adnexa that are Frequent Targets of GVHD
Duneia McManus |
10:27 a.m. |
21. Host immunomodulatory metabolite RvD1 as Anti-inflammatory Therapies to Treat Infectious and Non-infectious Ocular Diseases
Ashok Kumar, PhD |
10:34 a.m. |
22. Harnessing the Power of Macrophage Secretome to Combat Corneal Scarring Following microbial keratitis
Gink Yang, PhD |
10:41 a.m. |
23. Role of T Regulatory Cells in Modulating Angiogenesis in a Murine Model of Diabetic Corneal Neovascularization
Dr. Francesca Kahale |
10:48 a.m. |
BREAK and Posters
|
11:15 a.m. |
Introduction -- Thygeson Lecture
Thygeson Lecture: "Will the Last Case of Trachoma Please Stand Up?"
Thomas Lietman, MD
Ruth Lee and Phillips Thygeson Distinguished Professor
Department of Ophthalmology and Department of Epidemiology & Biostatistics
and Director, Francis I. Proctor Foundation
University of California, San Francisco
San Francisco, California |
11:55 a.m. |
Questions, Closing Comments, Awards |
12:00 p.m. |
Adjourn |
12:15 p.m. |
Business Luncheon - Huron Room (2nd floor) |